LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 36 filers reported holding LUMOS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,248 | +56.0% | 7,652 | +56.0% | 0.00% | – |
| Q2 2023 | $16,187 | +7.9% | 4,906 | +8.3% | 0.00% | – |
| Q1 2023 | $14,995 | +76.1% | 4,531 | +80.2% | 0.00% | – |
| Q4 2022 | $8,513 | -34.5% | 2,514 | +69.5% | 0.00% | – |
| Q3 2022 | $13,000 | -40.9% | 1,483 | -46.7% | 0.00% | – |
| Q2 2022 | $22,000 | -31.2% | 2,782 | -16.9% | 0.00% | – |
| Q1 2022 | $32,000 | +60.0% | 3,348 | +10.9% | 0.00% | – |
| Q4 2021 | $20,000 | +25.0% | 3,018 | +82.0% | 0.00% | – |
| Q3 2021 | $16,000 | -33.3% | 1,658 | -30.8% | 0.00% | – |
| Q2 2021 | $24,000 | +71.4% | 2,396 | +98.0% | 0.00% | – |
| Q1 2021 | $14,000 | -66.7% | 1,210 | 0.0% | 0.00% | – |
| Q4 2020 | $42,000 | -2.3% | 1,210 | -61.3% | 0.00% | – |
| Q3 2020 | $43,000 | -17.3% | 3,130 | -0.2% | 0.00% | – |
| Q2 2020 | $52,000 | +100.0% | 3,137 | +1.1% | 0.00% | – |
| Q1 2020 | $26,000 | – | 3,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 125,242 | $413,299 | 0.24% |
| Lion Point Capital, LP | 90,794 | $299,620 | 0.13% |
| Greenwich Wealth Management LLC | 76,341 | $252 | 0.03% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 25,760 | $85,008 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| Leucadia National | 120,651 | $398,148 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |